Dementia Risk and Your Genetics
By the ExomeDNA Research Team | Last reviewed May 2026
Dementia is a group of conditions that impair memory, thinking, and daily functioning. It is not a single disease but a cluster of symptoms most often caused by Alzheimer's disease or vascular injury. Twin studies suggest heritability between 40 and 70 percent, with APOE carrying the strongest known genetic association. Below: how variants shape susceptibility, the genes identified in large genome-wide studies, and what research suggests about modifiable factors.
What is Dementia?
Dementia describes a persistent decline in cognitive ability — memory, reasoning, language, or problem-solving — severe enough to interfere with daily life. It is not a normal part of aging, and its causes are biologically distinct from ordinary age-related memory lapses.
Alzheimer's disease accounts for roughly 60 to 70 percent of dementia cases worldwide. Vascular dementia, caused by reduced blood flow to the brain, is the second most common form. Less common subtypes include Lewy body dementia and frontotemporal dementia, each with distinct biology. Many people carry features of more than one type simultaneously. The shared feature across subtypes is progressive neuronal dysfunction, though mechanisms, timelines, and genetic contributors differ substantially.
Genetics does not predetermine dementia. Rather, inherited variants shift the statistical landscape of susceptibility — raising or lowering the likelihood of developing a condition that also depends heavily on age, cardiovascular health, lifestyle, and chance.
The genetics behind Dementia
The genetic architecture of dementia is polygenic: many variants scattered across the genome each contribute a modest effect. Their combined influence interacts with age and environment. No single variant — with the partial exception of APOE — determines whether dementia develops.
APOE encodes apolipoprotein E, a protein that transports lipids through the bloodstream and plays a central role in clearing amyloid peptides from the brain. One variant configuration — the ε4 allele — consistently shows the strongest common genetic association with late-onset Alzheimer's disease across population studies worldwide. Research shows that carrying ε4 variants is associated with meaningfully elevated susceptibility compared to the general population average. (Harper et al. 2022)[1]
BIN1 (bridging integrator 1) encodes a protein involved in membrane curvature, vesicle trafficking, and tau protein dynamics in neurons. Multiple large genome-wide studies independently identify the region near BIN1 as one of the most replicated non-APOE signals for dementia susceptibility. The BIN1 protein interacts with tau, which accumulates in Alzheimer's pathology, suggesting a mechanistic link to tau-related neurodegeneration.
ACE (angiotensin-converting enzyme) is best known for converting angiotensin I to angiotensin II in the cardiovascular system, regulating blood pressure. Variants near ACE have been associated with dementia in genome-wide analyses, likely reflecting the role of vascular function in brain health. The ACE signal is an example of how cardiovascular genetic architecture and neurodegeneration overlap.
PICALM encodes phosphatidylinositol-binding clathrin assembly protein, which mediates clathrin-dependent endocytosis — the cellular process for internalizing surface molecules, including amyloid precursor protein fragments. Several large studies identify the PICALM locus as a replicated dementia signal independent of APOE.
ABCA7 encodes an ATP-binding cassette transporter involved in lipid homeostasis and phagocytic clearance of cellular debris. Loss-of-function variants in ABCA7 have been associated with impaired clearance pathways, and the gene has been implicated in dementia susceptibility across multiple ancestry groups. (MEGAVCID Consortium 2024)[2]
ADAM10 (a disintegrin and metalloproteinase domain-containing protein 10) is a sheddase enzyme involved in the non-amyloidogenic processing of amyloid precursor protein. Variants near ADAM10 have been identified in dementia GWAS analyses. Higher ADAM10 activity favors the non-amyloid cleavage pathway, providing one potential mechanistic connection to Alzheimer's pathology.
Beyond these named loci, genome-wide analyses have identified additional signals in genes involved in immune function, complement activation, synaptic biology, and neuroinflammation — reflecting the multifactorial biology of this condition.
Genome-wide association research has identified dozens of loci associated with dementia susceptibility across ancestries, with the APOE locus showing the strongest and most consistently replicated effect in population studies.[1]
What the research says
Research base: Robust. The genetic architecture of dementia, particularly late-onset Alzheimer's disease, has been studied in large international cohorts for three decades. Genome-wide association studies have replicated findings across multiple ancestries and diverse population samples, establishing a well-characterized set of risk loci.
Harper et al. (2022) examined incident dementia in a community-based cohort, using genome-wide methods to identify genetic variants associated with dementia onset and progression. (Harper et al. 2022)[1] A subsequent large meta-analysis of all-cause and vascular dementia extended these findings to broader population groups and multiple dementia subtypes, reinforcing the central role of APOE and identifying additional contributing loci. (MEGAVCID Consortium 2024)[2]
These studies collectively support a picture in which genetics shapes predisposition but does not determine outcomes. Environmental and lifestyle factors — cardiovascular health, sleep quality, cognitive engagement, alcohol use, and tobacco exposure — modulate the expression of genetic background across the life course. Critically, people with identical genetic profiles can have very different outcomes depending on these factors.
For a full description of how genetic signals are evaluated and ranked, see our methodology page for the complete statistical approach.
Community-based and population-scale genome-wide research identifies APOE, BIN1, ACE, and PICALM among the strongest common genetic signals for dementia susceptibility, with findings replicated across independent cohorts and ancestries. (Harper et al. 2022; MEGAVCID Consortium 2024)[1][2]
How Dementia affects you
Dementia's impact depends on subtype, rate of progression, and age of onset. Early-stage cognitive changes are often subtle — misplaced items, difficulty finding words, reduced efficiency at complex tasks. Middle and later stages bring more profound memory impairment, behavioral changes, difficulty with daily activities, and increasing reliance on caregivers.
The genetic profile ExomeDNA reports reflects common inherited variation — primarily loci identified in genome-wide association studies — and does not capture rare causal mutations. Rare highly penetrant variants in genes such as APP, PSEN1, and PSEN2 are associated with familial early-onset Alzheimer's disease and require clinical genetic testing through a medical professional. For those with a strong family history of early-onset dementia (onset before age 65), a clinical genetics consultation is the appropriate path.
For the vast majority of people, dementia susceptibility is genuinely polygenic: many variants of small individual effect combine with lifestyle factors, vascular health, sleep, and cognitive reserve built over a lifetime. A higher polygenic profile shifts the statistical distribution of susceptibility but is not predictive for any individual — some people with substantial genetic loading never develop dementia; others with minimal genetic loading do.
Working with your profile
What research suggests about modifiable factors
The following factors have been studied in relation to dementia susceptibility, with varying levels of evidence:
- Cardiovascular health — Midlife hypertension is associated with elevated long-term dementia susceptibility independent of genetics. Managing blood pressure appears to reduce this association. (Harper et al. 2022)[1]
- Physical activity — Regular aerobic exercise has been associated with reduced dementia incidence across multiple observational cohorts and is one of the most consistently cited modifiable factors in the research literature.
- Sleep quality — Insufficient or fragmented sleep, particularly reduced slow-wave sleep, is linked to accelerated amyloid accumulation in neuroimaging research.
- Cognitive engagement — Higher educational attainment and sustained mental activity across the lifespan are associated with what researchers term cognitive reserve — a functional buffer against clinical symptom onset even when pathological burden is present.
- Alcohol and tobacco use — Heavy alcohol consumption and smoking are independently associated with elevated dementia susceptibility and appear to interact with genetic background in population studies.
- Social connection — Social isolation in later life is associated with accelerated cognitive decline in longitudinal research, independent of other known factors.
These modifiable factors do not eliminate inherited predisposition. The APOE signal does not override lifestyle choices; lifestyle choices do not override genetics. Both operate simultaneously across the lifespan.
Related traits and genes
Dementia shares genetic signals with several related traits in your ExomeDNA profile. Variants in genes associated with dementia susceptibility overlap with those implicated in cardiovascular risk, lipid metabolism, and neurological function.
Related traits in Brain & Mental Health:
- Cognitive function — overlapping signals in synaptic and neurodevelopmental pathways
- Memory performance — APOE and BIN1 appear in both trait architectures
- Neurological conditions risk — vascular-neurological pathway overlap
Cross-category related traits:
- Cardiovascular disease risk — ACE and lipid-pathway gene overlap
- HDL cholesterol genetics — APOE is a major lipid transport gene; its effects on cholesterol and dementia share a biological root
The APOE gene influences multiple traits across your ExomeDNA profile — lipid levels, cardiovascular risk, and cognitive susceptibility all carry APOE as a contributor. Each trait page reflects APOE's evidence in that specific context.
Frequently asked questions
Does carrying APOE ε4 variants mean Alzheimer's disease is inevitable? No. Carrying APOE ε4 alleles raises statistical susceptibility compared to the population average, but many people who carry these variants do not develop Alzheimer's disease in their lifetime. Genetics shapes predisposition; age, lifestyle, and cardiovascular health all contribute alongside inherited factors.
Is dementia a purely genetic condition? No. Twin studies estimate heritability at 40 to 70 percent, meaning a substantial portion of susceptibility is inherited — but that also means 30 to 60 percent of the variation is explained by non-genetic factors. Cardiovascular health, sleep, cognitive engagement, and social connection all play meaningful documented roles.
What is the difference between dementia and Alzheimer's disease? Alzheimer's disease is the most common cause of dementia, accounting for roughly 60 to 70 percent of cases globally. Dementia is the broader clinical category — a syndrome of progressive cognitive decline — that Alzheimer's, vascular injury, Lewy body pathology, and other causes can produce. Most of the genes identified in large-scale dementia genetics (APOE, BIN1, PICALM) predominantly reflect Alzheimer's-type pathology.
Does the ExomeDNA dementia result cover rare early-onset mutations? No. Rare highly penetrant mutations in APP, PSEN1, and PSEN2 that cause familial early-onset Alzheimer's disease are not captured by ExomeDNA's polygenic approach. Individuals with a family history of early-onset dementia (before age 65) should consult a genetic counselor for clinical-grade assessment.
Can lifestyle changes meaningfully affect genetic dementia susceptibility? Research supports that modifiable factors — cardiovascular fitness, blood pressure management, sleep quality, and cognitive engagement — independently affect dementia susceptibility. These factors do not eliminate inherited background, but the evidence suggests they shift the balance of risk in meaningful directions across a lifetime.
References
Harper AR, Nayee S, Topol EJ, et al. (2022). Genome-Wide Association Study of Incident Dementia in a Community-Based Sample. Journal of Alzheimer's Disease. PMID: 35694926.
MEGAVCID Consortium (2024). A Genome-Wide Association Meta-Analysis of All-Cause and Vascular Dementia. Alzheimers Dement. PMID: 39046104.
--- Data sources: GWAS Catalog (NHGRI-EBI, accessed 2026-05-24) · Open Targets Platform (CC0 1.0, accessed 2026-05-24) · ClinVar (NCBI, accessed 2026-05-24)
This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-24.